Evidence map›Paper›PMID 25835535›Full record

ArticleViruses2015

Tenth International Foamy Virus Conference 2014--achievements and perspectives.

Magdalena Materniak, Piotr Kubiś, Marzena Rola-Łuszczak, Arifa S Khan, Florence Buseyne, Dirk Lindemann, Martin Löchelt, Jacek Kuźmak

Open access · goldAbstract readConference Proceedings
In one paragraph

Article in Viruses, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Magdalena MaterniakDepartment of Biochemistry, National Veterinary Research Institute, 24-100 Pulawy, Poland. magdalena.materniak@piwet.pulawy.pl.
Piotr KubiśDepartment of Biochemistry, National Veterinary Research Institute, 24-100 Pulawy, Poland. kubip@piwet.pulawy.pl.
Marzena Rola-ŁuszczakDepartment of Biochemistry, National Veterinary Research Institute, 24-100 Pulawy, Poland.
Arifa S KhanLaboratory of Retroviruses, Division of Viral Products, OVRR, CBER, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. arifa.khan@fda.hhs.gov.
Florence BuseyneUnité d'épidémiologie et Physiopathologie des Virus Oncogènes, Institut Pasteur, 75015 Paris, France. florence.buseyne@pasteur.fr.
Dirk LindemannInstitute of Virology, Medical Faculty "Carl Gustav Carus", Technische Universität Dresden, 01307 Dresden, Germany. Dirk.Lindemann@tu-dresden.de.
Martin LöcheltDepartment of Genome Modifications and Carcinogenesis, German Cancer Research Center, 69121 Heidelberg, Germany. m.loechelt@dkfz.de.
Jacek KuźmakDepartment of Biochemistry, National Veterinary Research Institute, 24-100 Pulawy, Poland. jkuzmak@piwet.pulawy.pl.
National Veterinary Research Institute · PLGerman Cancer Research Center · DEInstitut Pasteur · FRUnited States Food and Drug Administration · USUniversity Hospital Carl Gustav Carus · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For the past two decades, scientists from around the world, working on different aspects of foamy virus (FV) research, have gathered in different research institutions almost every two years to present their recent results in formal talks, to discuss their ongoing studies informally, and to initiate fruitful collaborations. In this report we review the 2014 anniversary conference to share the meeting summary with the virology community and hope to arouse interest by other researchers to join this exciting field. The topics covered included epidemiology, virus molecular biology, and immunology of FV infection in non-human primates, cattle, and humans with zoonotic FV infections, as well as recent findings on endogenous FVs. Several topics focused on virus replication and interactions between viral and cellular proteins. Use of FV in biomedical research was highlighted with presentations on using FV vectors for gene therapy and FV proteins as scaffold for vaccine antigen presentation. On behalf of the FV community, this report also includes a short tribute to commemorate Prof. Axel Rethwilm, one of the leading experts in the field of retrovirology and foamy viruses, who passed away 29 July 2014.

Indexed as

AnimalsBiomedical ResearchCattleHumansPrimatesRetroviridae InfectionsSpumavirus

Identifiers

PMID25835535
PMCPMC4411671
OpenAlexW2134525544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.